from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0667/rpoB

LFCtreatmentdescriptionclass of inhibitor

-0.855

Amikacinug/mL Amikacintranslation

-1.214

Cap5-10ug/mL Capreomycintranslation

-1.790

Rox10-50 ug/mL Roxithromycintranslation

0.944

SM2-5 ug/mL Streptomycintranslation

-1.703

Tet5-10 ug/mL Tetracyclinetranslation

0.743

Rif0.2-5ug/mL Rifampicintranscription

0.795

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.746

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.252

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.041

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.625

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.100

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.504

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.381

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.520

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.369

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.458

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.300

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.107

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.270

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.305

KCN5-20 ug/mL Potassium cyaniderespiration

-1.146

NaN30.2-2 mM Sodium aziderespiration

0.084

Nigericin50 uM Nigericinrespiration

-1.297

TRC10-150 ug/mL Triclosanrespiration

-1.373

TRZ10-25 ug/mL Thioridazinerespiration

1.712

Valinomycin0.5-10 uM Valinomycinrespiration

0.364

ZnSO42 mM ZnSO4respiration

0.587

menadione6-10 ug/mL Menadionerespiration

0.056

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.358

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.445

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.410

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.123

NRP_1Non-replicating persistence stage 1dosRassociated

0.951

Amp0.2mg/mL AmpicillincellWall

0.616

Cephalexin20-100 ug/mL CephalexincellWall

0.249

Cerulenin0.32-5 ug/mL CerulenincellWall

0.971

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.549

EMB10-20 ug/mL EthambutolcellWall

-0.059

Eta12-40 ug/mL EthionamidecellWall

0.237

INH0.2-0.4 ug/mL IsoniazidcellWall

0.277

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.019

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.303

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.562

BZA0.12 mg/mL BenzamidearomaticAmides

-0.154

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.259

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.262

H2O24 mM hydrogen peroxideDNAdamaging

0.632

Levo10 ug/mL LevofloxacinDNAdamaging

0.661

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.690

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.825

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.753

UVUV-irradiationDNAdamaging

0.176

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.057

Antimycin12.5-50 ug/mL Antimycin A?

0.483

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.519

PA_110-50 ug/mL Antitubercular compound PA-1?

0.532

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.334

PA8240.2-2 ug/mL PA-824?

-0.319

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.427

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.264

Verapamil50 uM Verapamil?

0.412

mercaptoethanol2 mM 2-Mercaptoethanol?

0.041

methoxatin10-20 ug/mL Methoxatin?